MultivisionDx
PrivateLast Round
Pre Seed
Dec 3, 2025
Total Funding Raised
$1.87M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
MultivisionDx operates in Healthcare & Life Sciences and is based in Helsinki. Its latest recorded funding round was a Pre Seed round in December 2025.
MultivisionDx is a biotechnology company that develops AI-powered decision-support tools for personalized diagnosis and treatment selection for solid cancers.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Precision Medicine, Biotechnology, Healthcare Analytics, Medical Imaging
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MultivisionDx Comparables
Compare MultivisionDx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nucleai | 76% | |
| DoMore Diagnostics | 76% | |
| Aignostics | 70% |
For institutional investors. Book with your work email.
MultivisionDx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Dec 3, 2025 | ||||
| Grant | Nov 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
MultivisionDx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Helsinki University Funds | Pre Seed |
| Business Finland | Grant |
| Antler | Pre Seed |
| Kaikarhenni Oy | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 3, 2025
$1.18M raised in Pre Seed round.
- Nov 1, 2022
$690K grant received from Business Finland
For institutional investors. Book with your work email.
MultivisionDx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MultivisionDx's valuation, stock price, and market status.
Is MultivisionDx a public or private company?
MultivisionDx is a private company.
What is the current stock price of MultivisionDx?
MultivisionDx is a private company, so its shares have no public market price. Caplight tracks MultivisionDx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MultivisionDx worth (valuation)?
Valuation information for MultivisionDx is not publicly available.
Can I buy MultivisionDx stock?
MultivisionDx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MultivisionDx's last funding round?
MultivisionDx's most recent funding round was Pre Seed on December 3, 2025.
Who are the main investors in MultivisionDx?
Key investors in MultivisionDx include Antler.
Will MultivisionDx IPO soon?
No public IPO plans have been announced for MultivisionDx.
How can I track MultivisionDx secondary market activity?
Caplight tracks bids, offers, and trades in MultivisionDx's shares on secondary markets.